Ironwood Pharmaceuticals, Inc. - (IRWD): Price and Financial Metrics

IRWD POWR Grades

• IRWD scores best on the Quality dimension, with a Quality rank ahead of 99.75% of US stocks.
• The strongest trend for IRWD is in Quality, which has been heading up over the past 178 days.
• IRWD's current lowest rank is in the Sentiment metric (where it is better than 23.95% of US stocks).

IRWD Stock Summary

• With a year-over-year growth in debt of -12.82%, IRONWOOD PHARMACEUTICALS INC's debt growth rate surpasses just 20.28% of about US stocks.
• In terms of volatility of its share price, IRWD is more volatile than just 5.98% of stocks we're observing.
• IRONWOOD PHARMACEUTICALS INC's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is 14.86%, greater than the shareholder yield of 87.77% of stocks in our set.
• If you're looking for stocks that are quantitatively similar to IRONWOOD PHARMACEUTICALS INC, a group of peers worth examining would be DVAX, EVBG, PWSC, CHGG, and PTRA.
• Visit IRWD's SEC page to see the company's official filings. To visit the company's web site, go to www.ironwoodpharma.com.

IRWD Valuation Summary

• In comparison to the median Healthcare stock, IRWD's price/sales ratio is 17.02% lower, now standing at 3.9.
• IRWD's EV/EBIT ratio has moved up 19.5 over the prior 160 months.

Below are key valuation metrics over time for IRWD.

IRWD Growth Metrics

Its 4 year cash and equivalents growth rate is now at 72.77%.
• The 5 year price growth rate now stands at -33.93%.
• Its 3 year cash and equivalents growth rate is now at 394.3%.

Over the past 34 months, IRWD's revenue has gone down $29,030,000.

The table below shows IRWD's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-12-31	410.596	273.763	175.065
2022-09-30	420.527	259.149	167.572
2022-06-30	415.637	265.122	173.1
2022-03-31	422.437	252.325	527.323
2021-12-31	413.753	261.895	528.448
2021-09-30	413.303	248.84	530.278

IRWD's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• IRWD has a Quality Grade of B, ranking ahead of 94.53% of graded US stocks.
• IRWD's asset turnover comes in at 0.622 -- ranking 50th of 682 Pharmaceutical Products stocks.
• LGND, COLL, and OMER are the stocks whose asset turnover ratios are most correlated with IRWD.

The table below shows IRWD's key quality metrics over time.